Justine Bellier

1.0k total citations
11 papers, 632 citations indexed

About

Justine Bellier is a scholar working on Molecular Biology, Clinical Biochemistry and Oncology. According to data from OpenAlex, Justine Bellier has authored 11 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Clinical Biochemistry and 3 papers in Oncology. Recurrent topics in Justine Bellier's work include Advanced Glycation End Products research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Justine Bellier is often cited by papers focused on Advanced Glycation End Products research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Justine Bellier collaborates with scholars based in Belgium, France and Japan. Justine Bellier's co-authors include Vincent Castronovo, Brunella Costanza, Andrei Turtoï, Olivier Peulen, Akeila Bellahcène, Marie‐Julie Nokin, Ijeoma Adaku Umelo, Philippe Delvenne, Philippe Karoyan and Nadège Kindt and has published in prestigious journals such as Oncogene, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Justine Bellier

11 papers receiving 627 citations

Peers

Justine Bellier
Sun Mi Hong South Korea
Yunxia Ma China
Yu Qi China
Julie Hwang United States
Xiphias Ge Zhu United States
Madhavi Bathina United States
Sun Mi Hong South Korea
Justine Bellier
Citations per year, relative to Justine Bellier Justine Bellier (= 1×) peers Sun Mi Hong

Countries citing papers authored by Justine Bellier

Since Specialization
Citations

This map shows the geographic impact of Justine Bellier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justine Bellier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justine Bellier more than expected).

Fields of papers citing papers by Justine Bellier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justine Bellier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justine Bellier. The network helps show where Justine Bellier may publish in the future.

Co-authorship network of co-authors of Justine Bellier

This figure shows the co-authorship network connecting the top 25 collaborators of Justine Bellier. A scholar is included among the top collaborators of Justine Bellier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justine Bellier. Justine Bellier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bizet, Martin, Justine Bellier, Marie‐Julie Nokin, et al.. (2023). Methylglyoxal: a novel upstream regulator of DNA methylation. Journal of Experimental & Clinical Cancer Research. 42(1). 78–78. 10 indexed citations
2.
Bellier, Justine, Marie‐Julie Nokin, Philippe Karoyan, et al.. (2019). Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer. Diabetes Research and Clinical Practice. 148. 200–211. 112 indexed citations
3.
Rademaker, Gilles, Brunella Costanza, Justine Bellier, et al.. (2019). Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis. Oncogenesis. 8(3). 21–21. 23 indexed citations
4.
Costanza, Brunella, Gilles Rademaker, Pascal De Tullio, et al.. (2019). Transforming growth factor beta‐induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration. International Journal of Cancer. 145(6). 1570–1584. 59 indexed citations
5.
Rademaker, Gilles, Laura Brohée, Marie‐Julie Nokin, et al.. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene. 37(32). 4398–4412. 49 indexed citations
6.
Kindt, Nadège, Géraldine Descamps, Justine Bellier, et al.. (2018). High infiltration of CD68+ macrophages is associated with poor prognoses of head and neck squamous cell carcinoma patients and is influenced by human papillomavirus. Oncotarget. 9(13). 11046–11059. 55 indexed citations
7.
Nokin, Marie‐Julie, Florence Durieux, Justine Bellier, et al.. (2017). Hormetic potential of methylglyoxal, a side-product of glycolysis, in switching tumours from growth to death. Scientific Reports. 7(1). 11722–11722. 62 indexed citations
8.
Kindt, Nadège, Géraldine Descamps, Justine Bellier, et al.. (2017). High stromal Foxp3-positive T cell number combined to tumor stage improved prognosis in head and neck squamous cell carcinoma. Oral Oncology. 67. 183–191. 28 indexed citations
9.
Costanza, Brunella, Ijeoma Adaku Umelo, Justine Bellier, Vincent Castronovo, & Andrei Turtoï. (2017). Stromal Modulators of TGF-β in Cancer. Journal of Clinical Medicine. 6(1). 7–7. 136 indexed citations
10.
Chiavarina, Barbara, Marie‐Julie Nokin, Justine Bellier, et al.. (2017). Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer. International Journal of Molecular Sciences. 18(1). 213–213. 55 indexed citations
11.
Kindt, Nadège, Géraldine Descamps, Justine Bellier, et al.. (2016). Langerhans cell number is a strong and independent prognostic factor for head and neck squamous cell carcinomas. Oral Oncology. 62. 1–10. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026